Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
How RFK Jr. might influence the FDA; Pharma's Q3 highlights; AbbVie's latest neuro buyout; and more
7 months ago
Weekly
BMS, J&J and AstraZeneca plea with appeals court to overturn drug price negotiations
7 months ago
Pharma
Law
Exclusive: Women’s health unicorn Maven Clinic cuts 10% of its workforce weeks after raising $125M
7 months ago
People
Health Tech
Heritage and Apotex to pay $49.1M in price-fixing settlement
7 months ago
Pharma
Law
Novo Nordisk claims late-stage MASH victory, continuing GLP-1's expansion
7 months ago
R&D
FDA removes hold on three CARsgen CAR-T trials; Ono passes on itolizumab
7 months ago
News Briefing
Exclusive: Blood stem cell therapy maker Garuda gets new CEO, adds $47M
7 months ago
Financing
Cell/Gene Tx
Baxter pulls IV products out of China to shift supply to the US
7 months ago
China
Manufacturing
Essa’s shares tank as it looks for options after abandoning prostate cancer drug
7 months ago
R&D
Biogen brings in medical chief as CFO plans retirement; MacroGenics CEO announces departure
7 months ago
Peer Review
Q&A with Obesity Society’s CEO as the field prepares for next-gen meds
7 months ago
Pharma
Following 2019 rejection, FDA adcomm votes against Lexicon's type 1 diabetes and CKD drug
7 months ago
FDA+
Teva fined €462.6M by European regulators over Copaxone patent and competition allegations
7 months ago
Pharma
Law
UCB's anti-tau Alzheimer's program fails Phase 2 primary endpoint, but highlights positive secondaries
7 months ago
R&D
Federal court backs FDA's approval of competitor to Jazz's sleep drug
7 months ago
Pharma
FDA+
‘Imitation is best form of flattery’: Regeneron CEO comments on Amgen’s Eylea biosimilar
7 months ago
R&D
Pharma
Q&A: Jade CEO talks about reverse merger and IgAN drugs
7 months ago
Startups
Deals
Gardasil demand in China sinks, and Merck expects the same next quarter
7 months ago
China
Pharma
WuXi in ‘early stages’ of CGT business review; Lonza exec becomes AGC Bio CEO
7 months ago
Manufacturing
Takeda says multiyear restructuring is 'on track'
7 months ago
R&D
Pharma
Argenx reports Vyvgart sales streak, bolstered by launch in rare neuro disorder
7 months ago
Pharma
Boehringer, Gubra stop work on obesity drug; Galapagos restarts CAR-T study
7 months ago
News Briefing
Why a prominent health tech VC keeps adjusting how it thinks about AI in healthcare
7 months ago
AI
Health Tech
Evommune raises $115M for I&I pipeline and prepares for Phase 2 results
7 months ago
Financing
Startups
First page
Previous page
82
83
84
85
86
87
88
Next page
Last page